Biotechnology Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers – Theriva Biologics (AMEX:TOVX) Read more
Biotechnology How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need – Theriva Biologics (AMEX:TOVX) Read more
Biotechnology Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology – Candel Therapeutics (NASDAQ:CADL), CG Oncology (NASDAQ:CGON) Read more
